US Stock MarketDetailed Quotes

Inovio Pharmaceuticals (INO)

Watchlist
  • 1.520
  • -0.060-3.80%
Close Jan 16 16:00 ET
  • 1.550
  • +0.030+1.97%
Post 16:51 ET
104.43MMarket Cap-0.56P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inovio Pharmaceuticals (INO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
65.34K
-73.83%217.76K
13.97%116.99K
0
-55.41%100.76K
0
-91.89%832.01K
-17.66%102.65K
Operating revenue
--0
--0
--65.34K
-73.83%217.76K
13.97%116.99K
--0
-55.41%100.76K
--0
-91.89%832.01K
-17.66%102.65K
Cost of revenue
Gross profit
Operating expense
-22.44%21.21M
-30.67%23.08M
-20.23%25.12M
-16.12%112.62M
-25.49%20.49M
7.55%27.35M
-10.65%33.3M
-28.55%31.48M
-51.68%134.26M
-50.96%27.5M
Selling and administrative expenses
-8.55%7.88M
-16.10%8.56M
-14.63%9.02M
-22.25%37M
-25.79%7.6M
-13.21%8.61M
-24.52%10.21M
-23.90%10.57M
-47.24%47.58M
-26.58%10.24M
-General and administrative expense
-8.55%7.88M
-16.10%8.56M
-14.63%9.02M
-22.25%37M
-25.79%7.6M
-13.21%8.61M
-24.52%10.21M
-23.90%10.57M
-47.24%47.58M
-26.58%10.24M
Research and development costs
-28.83%13.33M
-37.11%14.52M
-23.06%16.09M
-12.76%75.62M
-25.31%12.89M
20.84%18.73M
-2.75%23.09M
-30.70%20.91M
-53.81%86.68M
-59.04%17.25M
Operating profit
22.44%-21.21M
30.46%-23.08M
20.44%-25.05M
15.76%-112.4M
25.64%-20.37M
-9.22%-27.35M
10.38%-33.2M
28.37%-31.48M
50.13%-133.43M
51.04%-27.39M
Net non-operating interest income expense
-50.11%552.11K
-53.29%610.64K
-38.90%808.08K
-33.59%4.59M
-44.52%852.59K
-31.90%1.11M
-29.51%1.31M
-30.16%1.32M
95.87%6.91M
-2.44%1.54M
Non-operating interest income
-50.11%552.11K
-53.29%610.64K
-46.14%808.08K
-41.39%4.77M
-53.13%852.59K
-42.91%1.11M
-39.70%1.31M
-32.03%1.5M
70.08%8.13M
-3.69%1.82M
Non-operating interest expense
--0
--0
--0
-85.46%177.83K
--0
--0
--0
-43.27%177.83K
-2.49%1.22M
-9.94%282.33K
Other net income (expense)
-2,410.02%-24.84M
-200.84%-1.05M
1,579.62%4.55M
106.46%555.64K
-84.14%135.3K
110.23%1.08M
0.18%-347.54K
-121.81%-307.36K
36.79%-8.6M
1,024.61%853.29K
Gain on sale of security
-1,776.46%-22.31M
-5,273.30%-1.12M
669.27%3.85M
-16.49%4.89M
59.42%3.07M
706.74%1.33M
-102.26%-20.82K
-84.44%500.88K
174.57%5.85M
-30.99%1.93M
Earnings from equity interest
-281.84%-589.62K
332.24%776.37K
651.61%695.13K
-250.87%-1.17M
-380.11%-1.03M
51.25%324.25K
-313.27%-334.29K
-120.44%-126.02K
140.70%773.15K
-74.70%-214.61K
Special income (charges)
----
----
----
--0
--0
--0
----
----
---10.51M
--0
-Less:Impairment of capital assets
----
----
----
--0
--0
--0
----
----
--10.51M
--0
Other non- operating income (expenses)
-234.28%-1.94M
-9,387.85%-703.18K
99.93%-482
32.85%-3.16M
-121.77%-1.91M
-20,416.01%-579.82K
100.53%7.57K
71.88%-682.22K
-22.01%-4.71M
68.86%-860.91K
Income before tax
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.34%-135.12M
54.09%-25M
Income tax
Net income
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
Net income continuous Operations
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
Minority interest income
Net income attributable to the parent company
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-80.79%-45.5M
27.04%-23.52M
35.36%-19.69M
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
Basic earnings per share
2.25%-0.87
48.74%-0.61
61.07%-0.51
35.14%-3.95
44.44%-0.6
41.45%-0.89
26.09%-1.19
30.69%-1.31
56.72%-6.09
57.65%-1.08
Diluted earnings per share
2.25%-0.87
48.74%-0.61
61.07%-0.51
35.14%-3.95
44.44%-0.6
41.45%-0.89
26.09%-1.19
30.69%-1.31
56.72%-6.09
57.65%-1.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0065.34K-73.83%217.76K13.97%116.99K0-55.41%100.76K0-91.89%832.01K-17.66%102.65K
Operating revenue --0--0--65.34K-73.83%217.76K13.97%116.99K--0-55.41%100.76K--0-91.89%832.01K-17.66%102.65K
Cost of revenue
Gross profit
Operating expense -22.44%21.21M-30.67%23.08M-20.23%25.12M-16.12%112.62M-25.49%20.49M7.55%27.35M-10.65%33.3M-28.55%31.48M-51.68%134.26M-50.96%27.5M
Selling and administrative expenses -8.55%7.88M-16.10%8.56M-14.63%9.02M-22.25%37M-25.79%7.6M-13.21%8.61M-24.52%10.21M-23.90%10.57M-47.24%47.58M-26.58%10.24M
-General and administrative expense -8.55%7.88M-16.10%8.56M-14.63%9.02M-22.25%37M-25.79%7.6M-13.21%8.61M-24.52%10.21M-23.90%10.57M-47.24%47.58M-26.58%10.24M
Research and development costs -28.83%13.33M-37.11%14.52M-23.06%16.09M-12.76%75.62M-25.31%12.89M20.84%18.73M-2.75%23.09M-30.70%20.91M-53.81%86.68M-59.04%17.25M
Operating profit 22.44%-21.21M30.46%-23.08M20.44%-25.05M15.76%-112.4M25.64%-20.37M-9.22%-27.35M10.38%-33.2M28.37%-31.48M50.13%-133.43M51.04%-27.39M
Net non-operating interest income expense -50.11%552.11K-53.29%610.64K-38.90%808.08K-33.59%4.59M-44.52%852.59K-31.90%1.11M-29.51%1.31M-30.16%1.32M95.87%6.91M-2.44%1.54M
Non-operating interest income -50.11%552.11K-53.29%610.64K-46.14%808.08K-41.39%4.77M-53.13%852.59K-42.91%1.11M-39.70%1.31M-32.03%1.5M70.08%8.13M-3.69%1.82M
Non-operating interest expense --0--0--0-85.46%177.83K--0--0--0-43.27%177.83K-2.49%1.22M-9.94%282.33K
Other net income (expense) -2,410.02%-24.84M-200.84%-1.05M1,579.62%4.55M106.46%555.64K-84.14%135.3K110.23%1.08M0.18%-347.54K-121.81%-307.36K36.79%-8.6M1,024.61%853.29K
Gain on sale of security -1,776.46%-22.31M-5,273.30%-1.12M669.27%3.85M-16.49%4.89M59.42%3.07M706.74%1.33M-102.26%-20.82K-84.44%500.88K174.57%5.85M-30.99%1.93M
Earnings from equity interest -281.84%-589.62K332.24%776.37K651.61%695.13K-250.87%-1.17M-380.11%-1.03M51.25%324.25K-313.27%-334.29K-120.44%-126.02K140.70%773.15K-74.70%-214.61K
Special income (charges) --------------0--0--0-----------10.51M--0
-Less:Impairment of capital assets --------------0--0--0----------10.51M--0
Other non- operating income (expenses) -234.28%-1.94M-9,387.85%-703.18K99.93%-48232.85%-3.16M-121.77%-1.91M-20,416.01%-579.82K100.53%7.57K71.88%-682.22K-22.01%-4.71M68.86%-860.91K
Income before tax -80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.34%-135.12M54.09%-25M
Income tax
Net income -80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M
Net income continuous Operations -80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M
Minority interest income
Net income attributable to the parent company -80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -80.79%-45.5M27.04%-23.52M35.36%-19.69M20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M
Basic earnings per share 2.25%-0.8748.74%-0.6161.07%-0.5135.14%-3.9544.44%-0.641.45%-0.8926.09%-1.1930.69%-1.3156.72%-6.0957.65%-1.08
Diluted earnings per share 2.25%-0.8748.74%-0.6161.07%-0.5135.14%-3.9544.44%-0.641.45%-0.8926.09%-1.1930.69%-1.3156.72%-6.0957.65%-1.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -